Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Steven M. Yip"'
Autor:
Kim N. Chi, Steven M. Yip, Glenn Bauman, Stephan Probst, Urban Emmenegger, Christian K. Kollmannsberger, Patrick Martineau, Tamim Niazi, Frédéric Pouliot, Ricardo Rendon, Sebastien J. Hotte, David T. Laidley, Fred Saad
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1400-1415 (2024)
Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer and a therapeutic target. Lutetium-177 (177Lu)-PSMA-617 is the first radioligand therapy to be approved in Canada for use in patients with metastatic castration-resistan
Externí odkaz:
https://doaj.org/article/64b195e581c7483cb8fda268b1214380
Autor:
Safiya Karim, Jennifer Lowther, Gabriel Gyulay, Dylan O’Sullivan, Christopher J. D. Wallis, Steven M. Yip, Darren R. Brenner, Devon J. Boyne, Winson Y. Cheung
Publikováno v:
Current Oncology, Vol 30, Iss 9, Pp 8149-8158 (2023)
Introduction: Over the past decade, the treatment of metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly. Current guidelines suggest the use of androgen deprivation therapy (ADT) plus an additional systemic therapy, rega
Externí odkaz:
https://doaj.org/article/3d13741c0c444fc0ada6fdd1c670e619
Autor:
Simon R. Walker, Ramy Abdelsalam, Sunita Ghosh, Julie Livingstone, Nallasivam Palanisamy, Paul C. Boutros, Steven M. Yip, Susan P. Lees-Miller, Tarek A. Bismar
Publikováno v:
European Urology Open Science, Vol 29, Iss , Pp 93-101 (2021)
Background: Ataxia Telangiectasia Mutated (ATM) serine/threonine protein kinase is a known tumor suppressor, involved in DNA damage repair. It has prognostic and predictive therapeutic implications and is associated with aggressive prostate cancer (P
Externí odkaz:
https://doaj.org/article/6ee9b4c07d23483389622da0e4347712
Autor:
Steven M. Yip, Daniel E. Meyers, Jeff Sisler, Keith Wycliffe-Jones, Edward Kucharski, Christine Elser, Claire Temple-Oberle, Silvana Spadafora, Paris-Ann Ingledew, Meredith Giuliani, Sara Kuruvilla, Nureen Sumar, Vincent C. Tam
Publikováno v:
BMC Medical Education, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background This study aimed to determine the current state of oncology education in Canadian family medicine postgraduate medical education programs (FM PGME) and examine opinions regarding optimal oncology education in these programs. Metho
Externí odkaz:
https://doaj.org/article/cae1dfba240343e4b985f2e250ee379f
Autor:
Gabriel Oh, Art Petronis, Kim N. Chi, Anthony M. Joshua, Rafal Kustra, Andrew Kwan, Miki Susic, Steven M. Yip, Daniel E. Groot, Algimantas Kriščiūnas, Juozas Gordevičius
Summary of samples retained and used for analysis after quality control: individual distribution across treatment visits, treatment follow-up visit times, and measured PSA levels.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ce0c3c7cd609b3d6c8ff1b3862b76d
https://doi.org/10.1158/1078-0432.22470324
https://doi.org/10.1158/1078-0432.22470324
Autor:
Gabriel Oh, Art Petronis, Kim N. Chi, Anthony M. Joshua, Rafal Kustra, Andrew Kwan, Miki Susic, Steven M. Yip, Daniel E. Groot, Algimantas Kriščiūnas, Juozas Gordevičius
Clinical information of all samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32345d1b58ada919898a8369546dce15
https://doi.org/10.1158/1078-0432.22470321.v1
https://doi.org/10.1158/1078-0432.22470321.v1
Autor:
Gabriel Oh, Art Petronis, Kim N. Chi, Anthony M. Joshua, Rafal Kustra, Andrew Kwan, Miki Susic, Steven M. Yip, Daniel E. Groot, Algimantas Kriščiūnas, Juozas Gordevičius
DAVID analysis of AA-DMPs at FDR q < 0.2 and AA-DVPs measured across patient groups for each visit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6197886c732ba0d60a8b51de1e19d2
https://doi.org/10.1158/1078-0432.22470315.v1
https://doi.org/10.1158/1078-0432.22470315.v1
Autor:
Gabriel Oh, Art Petronis, Kim N. Chi, Anthony M. Joshua, Rafal Kustra, Andrew Kwan, Miki Susic, Steven M. Yip, Daniel E. Groot, Algimantas Kriščiūnas, Juozas Gordevičius
Supplementary methods, supplementary table legends, and all supplementary figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a59731325e40e4b81ca91643bf5238
https://doi.org/10.1158/1078-0432.22470327.v1
https://doi.org/10.1158/1078-0432.22470327.v1
Autor:
Gabriel Oh, Art Petronis, Kim N. Chi, Anthony M. Joshua, Rafal Kustra, Andrew Kwan, Miki Susic, Steven M. Yip, Daniel E. Groot, Algimantas Kriščiūnas, Juozas Gordevičius
Purpose: Primary resistance to abiraterone acetate (AA), a key medication for the treatment of metastatic castration-resistant prostate cancer, occurs in 20% to 40% of patients. We aim to identify predictive biomarkers for AA-treatment response and u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c75017e6427e5f6b0a4fb461a37538
https://doi.org/10.1158/1078-0432.c.6527517.v1
https://doi.org/10.1158/1078-0432.c.6527517.v1
Autor:
Gabriel Oh, Art Petronis, Kim N. Chi, Anthony M. Joshua, Rafal Kustra, Andrew Kwan, Miki Susic, Steven M. Yip, Daniel E. Groot, Algimantas Kriščiūnas, Juozas Gordevičius
List of significant AA-DVPs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5398f0b6cb3bb5921f849a47ebb78754
https://doi.org/10.1158/1078-0432.22470312
https://doi.org/10.1158/1078-0432.22470312